Novartis AG is committed to improving health and well-being through innovative products and services.
Novartis Ag-adr had an annual average earnings growth of 9.6% over the past 10 years.
Novartis, for instance, , has been criticized for failing to conduct an annual say-on-pay shareholder.
FORBES: The Novartis Board Insulted Shareholders With Hush Money For Dan Vasella
Novartis, as Preet Bharara, the US Attorney in Manhattan points out, Novartis is a repeat offender.
FORBES: Did Novartis Violate Its Corporate Integrity Agreement?
Novartis is closing in on the number five spot, while Roche is number nine.
GlaxoSmithKline and Novartis are working on similar medicines, but are thought to be far behind.
Bristol-Myers (its new Zelmac partner) is one candidate, with a market cap 20% more than Novartis'.
The question Novartis' studies are asking is exactly how competitive this one will be.
Then came Gleevec, from Novartis (nyse: NVS - news - people ).
Based on those results, Novartis has quickly proceeded with final stage trials, which began in January.
One big question: If Novartis buys Aventis, would that motivate Pfizer to do another big deal?
Novartis ( NVS), Roche ( RHHBY), some of the best health-care stocks in the world.
Novartis is taking the bold move of actually comparing its drug to Celebrex and Vioxx.
Eventually, Novartis could use data from 31, 000 patients to back up its marketing claims.
His firm faces competition from small shops such as England's Biotica Technology and giants like Novartis.
Novartis said in a statement that it disputes the claims and will defend itself.
Novartis sold 62 million courses of its malaria drug, Coartem, at cost to poor African countries.
Novartis, Abbott Laboratories and Boehringer Ingelheim are all thought to be pursuing hedgehog programs.
The drug is off-patent, but Novartis, which makes it, has said it disagrees with the findings.
However, after the Novartis statement was released, Aventis said it planned to talk with Novartis further.
Reuters reported that the French government said today it had no comment on the Novartis statement.
There is the occasional breakthroughs like Gleevec from Novartis that extend survival for years.
Government regulators today cleared Gleevec, Novartis' oral treatment for a rare but life-threatening type of leukemia.
It expects to compete with Sanofi-Aventis, GlaxoSmithKline and Novartis, which plans to buy Chiron.
Novartis was trading down slightly Thursday morning, while the other three stocks were all up slightly.
FORBES: Markets Inch Up Slowly After Jobs, Japan Weaken Confidence
Novartis, a Basel, Switzerland-based drug giant, nonetheless chose to place its research headquarters in Cambridge, Mass.
FORBES: The Most Innovative Countries In Biology And Medicine
Ranjit Shahani, vice chairman and managing director of Novartis's business in India, criticized the ruling.
Does Novartis' bid for Chiron signal the beginning of a new golden age for virus-fighting vaccines?
Analysts have believed that some version of the Novartis-Chiron deal was likely to go through.
The project puts Basel, Switzerland-based Novartis on a collision course with rivals Pfizer and Roche.
应用推荐